Cargando…
Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation
Autores principales: | Munavalli, Girish Gilly, Knutsen-Larson, Siri, Lupo, Mary P., Geronemus, Roy G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923909/ https://www.ncbi.nlm.nih.gov/pubmed/33681439 http://dx.doi.org/10.1016/j.jdcr.2021.02.018 |
Ejemplares similares
-
“COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment”
por: Munavalli, Girish Gilly, et al.
Publicado: (2021) -
Delayed inflammatory reaction to hyaluronic acid filler following Shingrix and Fluzone vaccines treated with lisinopril
por: Witt, Jacqueline, et al.
Publicado: (2022) -
Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016) -
Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)